Cerebral mGluR5 availability contributes to elevated sleep need and behavioral adjustment after sleep deprivation

  1. Sebastian C Holst
  2. Alexandra Sousek
  3. Katharina Hefti
  4. Sohrab Saberi-Moghadam
  5. Alfred Buck
  6. Simon M Ametamey
  7. Milan Scheidegger
  8. Paul Franken
  9. Anke Henning
  10. Erich Seifritz
  11. Mehdi Tafti
  12. Hans-Peter Landolt  Is a corresponding author
  1. University of Zürich, Switzerland
  2. University of Lausanne, Switzerland
  3. University Hospital Zürich, Switzerland
  4. Swiss Federal Institute of Technology, Switzerland

Abstract

Increased sleep time and intensity quantified as low-frequency brain electrical activity after sleep loss demonstrate that sleep need is homeostatically regulated, yet the underlying molecular mechanisms remain elusive. We here demonstrate that metabotropic glutamate receptors of subtype 5 (mGluR5) contribute to the molecular machinery governing sleep-wake homeostasis. Using positron emission tomography, magnetic resonance spectroscopy, and electroencephalography in humans, we find that increased mGluR5 availability after sleep loss tightly correlates with behavioral and electroencephalographic biomarkers of elevated sleep need. These changes are associated with altered cortical myo-inositol and glycine levels, suggesting sleep loss-induced modifications downstream of mGluR5 signaling. Knock-out mice without functional mGluR5 exhibit severe dysregulation of sleep-wake homeostasis, including lack of recovery sleep and impaired behavioral adjustment to a novel task after sleep deprivation. The data suggest that mGluR5 contribute to the brain's coping mechanisms with sleep deprivation and point to a novel target to improve disturbed wakefulness and sleep.

Article and author information

Author details

  1. Sebastian C Holst

    Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3657-4535
  2. Alexandra Sousek

    Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Katharina Hefti

    Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  4. Sohrab Saberi-Moghadam

    Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  5. Alfred Buck

    Division of Nuclear Medicine, University Hospital Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  6. Simon M Ametamey

    Center for Radiopharmaceutical Sciences, Swiss Federal Institute of Technology, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  7. Milan Scheidegger

    Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  8. Paul Franken

    Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2500-2921
  9. Anke Henning

    Center for Radiopharmaceutical Sciences, Swiss Federal Institute of Technology, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  10. Erich Seifritz

    Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zürich, Zürich, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  11. Mehdi Tafti

    Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6997-3914
  12. Hans-Peter Landolt

    Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland
    For correspondence
    landolt@pharma.uzh.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0887-9403

Funding

Swiss National Science Foundation (320030_135414)

  • Hans-Peter Landolt

Universität Zürich (Sleep & Health)

  • Hans-Peter Landolt

NCCR Neural Plasticity and Repair

  • Erich Seifritz
  • Hans-Peter Landolt

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were carried out in accordance with the regulations of the Swiss Federal and State of Vaud Veterinary Offices (No. 2699.0).

Human subjects: All experimental procedures were conducted in accordance with the declaration of Helsinki (1964) and approved by the cantonal (ethics committee for research on human subjects of the canon of Zurich [Reference Nr. EK-Nr. 786] and Swiss federal authorities for research on human (Swiss Federal Institute of Public Health, Reference Nr. 464-0002-6/08.005701) subjects.

Copyright

© 2017, Holst et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,094
    views
  • 386
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sebastian C Holst
  2. Alexandra Sousek
  3. Katharina Hefti
  4. Sohrab Saberi-Moghadam
  5. Alfred Buck
  6. Simon M Ametamey
  7. Milan Scheidegger
  8. Paul Franken
  9. Anke Henning
  10. Erich Seifritz
  11. Mehdi Tafti
  12. Hans-Peter Landolt
(2017)
Cerebral mGluR5 availability contributes to elevated sleep need and behavioral adjustment after sleep deprivation
eLife 6:e28751.
https://doi.org/10.7554/eLife.28751

Share this article

https://doi.org/10.7554/eLife.28751

Further reading

    1. Neuroscience
    Nicolas Langer, Maurice Weber ... Ce Zhang
    Tools and Resources

    Memory deficits are a hallmark of many different neurological and psychiatric conditions. The Rey–Osterrieth complex figure (ROCF) is the state-of-the-art assessment tool for neuropsychologists across the globe to assess the degree of non-verbal visual memory deterioration. To obtain a score, a trained clinician inspects a patient’s ROCF drawing and quantifies deviations from the original figure. This manual procedure is time-consuming, slow and scores vary depending on the clinician’s experience, motivation, and tiredness. Here, we leverage novel deep learning architectures to automatize the rating of memory deficits. For this, we collected more than 20k hand-drawn ROCF drawings from patients with various neurological and psychiatric disorders as well as healthy participants. Unbiased ground truth ROCF scores were obtained from crowdsourced human intelligence. This dataset was used to train and evaluate a multihead convolutional neural network. The model performs highly unbiased as it yielded predictions very close to the ground truth and the error was similarly distributed around zero. The neural network outperforms both online raters and clinicians. The scoring system can reliably identify and accurately score individual figure elements in previously unseen ROCF drawings, which facilitates explainability of the AI-scoring system. To ensure generalizability and clinical utility, the model performance was successfully replicated in a large independent prospective validation study that was pre-registered prior to data collection. Our AI-powered scoring system provides healthcare institutions worldwide with a digital tool to assess objectively, reliably, and time-efficiently the performance in the ROCF test from hand-drawn images.

    1. Neuroscience
    Masahiro Takigawa, Marta Huelin Gorriz ... Daniel Bendor
    Research Article

    During rest and sleep, memory traces replay in the brain. The dialogue between brain regions during replay is thought to stabilize labile memory traces for long-term storage. However, because replay is an internally-driven, spontaneous phenomenon, it does not have a ground truth - an external reference that can validate whether a memory has truly been replayed. Instead, replay detection is based on the similarity between the sequential neural activity comprising the replay event and the corresponding template of neural activity generated during active locomotion. If the statistical likelihood of observing such a match by chance is sufficiently low, the candidate replay event is inferred to be replaying that specific memory. However, without the ability to evaluate whether replay detection methods are successfully detecting true events and correctly rejecting non-events, the evaluation and comparison of different replay methods is challenging. To circumvent this problem, we present a new framework for evaluating replay, tested using hippocampal neural recordings from rats exploring two novel linear tracks. Using this two-track paradigm, our framework selects replay events based on their temporal fidelity (sequence-based detection), and evaluates the detection performance using each event's track discriminability, where sequenceless decoding across both tracks is used to quantify whether the track replaying is also the most likely track being reactivated.